Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT06773429Completed

Estradiol and Brain Age

Role: lead

NCT06711809Not Yet Recruiting

Sleep, Oxytocin and Reward Processing in Women in the Postpartum Phase

Role: lead

NCT06690866Recruiting

Negative Emotionality and Epigenetics During Puberty

Role: lead

NCT06426459Not Yet Recruiting

Social Media Usage in Adolescent Girls

Role: lead

NCT06346457Not Yet Recruiting

Breast Cancer & Antiestrogenic Therapy & Brain

Role: lead

NCT06312033Not ApplicableCompleted

Estradiol's Effect on Brain Volume and Connectivity

Role: lead

NCT06204016Recruiting

Estradiol and Stress Reactivity in Women

Role: lead

NCT06222749Not ApplicableRecruiting

Oxytocin and Reward Processing in Women

Role: lead

All 8 trials loaded